Buckle Up: DOJ Initiates Rulemaking to Reschedule Marijuana
FDA Law Blog
MAY 21, 2024
The 2016 reviews concluded that marijuana continued to meet schedule I criteria for having a high potential for abuse, no currently accepted medical use in treatment in the U.S., and lacked accepted safety for use under medical supervision. 29, 2023) (“Basis”); NPRM at 44,603. 21 U.S.C. § 21 U.S.C. § 21 U.S.C. § NPRM at 44,601.
69 
Let's personalize your content